ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1573–1584 of 2020 project topics
Glycogen Storage Disease Type I GSD-Ia Testing
Applying G6PC and SLC37A4 gene testing for diagnosing GSD type Ia and Ib and distinguishing from other hypoglycemia-causing disorders.
Genetic Basis of Glycogen Storage Diseases Click to view more details →
Newborn Screening for Glycogen Storage Diseases
Evaluating second-tier molecular testing for GSD conditions detected by elevated biomarkers on expanded newborn screening programs.
Genetic Basis of Glycogen Storage Diseases Click to view more details →
GSD Type III Debranching Enzyme Mutation SaaS Platform
A cloud-based diagnostic platform that identifies and classifies AGL gene mutations associated with Cori disease using advanced bioinformatics algorithms and variant interpretation workflows. This service enables laboratories to offer rapid, accurate GSD Type III genetic testing with automated reporting, generating recurring subscription revenue from clinical and research institutions.
Genetic Basis of Glycogen Storage Diseases Click to view more details →
Glycogen Synthase GYS2 Gene Panel Commercial Diagnostic Kit
A ready-to-use molecular diagnostic kit that targets GYS2 gene variants responsible for glycogen storage disease Type 0 with high-throughput sequencing capability and interpretive software. This product captures market share in the rare disease diagnostics space while enabling clinical labs to monetize through per-test fees and bulk licensing agreements.
Genetic Basis of Glycogen Storage Diseases Click to view more details →
Phosphorylase Kinase PHKG2 Variant Interpretation Web Tool
An AI-powered web application that analyzes PHKG2 mutations in GSD Type IX patients and provides clinical interpretation, inheritance pattern analysis, and phenotype prediction with customizable reporting templates. The platform generates revenue through tiered subscription models for individual practitioners, hospital systems, and international diagnostic networks seeking automated variant curation.
Genetic Basis of Glycogen Storage Diseases Click to view more details →
Liver Glycogen Phosphorylase PYGL Gene Mutation Database
A comprehensive, continuously updated commercial database cataloging PYGL gene variants associated with GSD Type VI and VII with phenotype-genotype correlations, clinical outcome data, and treatment response metrics. This proprietary resource generates revenue through enterprise licensing to pharmaceutical companies, research institutions, and clinical laboratories conducting precision medicine studies.
Genetic Basis of Glycogen Storage Diseases Click to view more details →
Glucose-6-Phosphatase Catalytic Subunit G6PC Digital Registry Platform
A HIPAA-compliant patient registry platform that collects clinical data from GSD Type Ia patients carrying G6PC mutations, enabling real-world evidence generation for therapeutic development and natural history studies. The platform monetizes through subscription fees from pharmaceutical companies, contract research organizations, and patient advocacy groups leveraging the data for drug development pipelines.
Genetic Basis of Glycogen Storage Diseases Click to view more details →
Multi-Gene GSD Carrier Screening Commercial Panel Service
An expanded carrier screening service that simultaneously tests for mutations in GSD-associated genes including LDHA, PFKM, and PGAM2 for reproductive risk assessment and population genetic studies. This service delivers revenue through direct-to-consumer testing partnerships, obstetric clinic integrations, and data licensing agreements with genetic epidemiology research consortia.
Genetic Basis of Glycogen Storage Diseases Click to view more details →
Dent Disease CLCN5 and OCRL Gene Testing
Developing molecular testing for CLCN5 variants causing Dent disease type 1 and OCRL mutations causing Dent disease type 2 for diagnosis.
Genetic Basis of Kidney Tubular Disorders Click to view more details →
Lowe Syndrome OCRL Molecular Diagnosis
Characterizing OCRL pathogenic variants causing oculocerebrorenal syndrome for molecular diagnosis in males with cataracts, intellectual disability, and Fanconi syndrome.
Genetic Basis of Kidney Tubular Disorders Click to view more details →
Hereditary Fanconi Syndrome Gene Identification
Using WES for identifying novel causative genes in hereditary Fanconi syndrome patients without mutations in known tubular disorder genes.
Genetic Basis of Kidney Tubular Disorders Click to view more details →
Renal Tubular Acidosis Genetic Classification
Testing ATP6V1B1, ATP6V0A4, and SLC4A1 variants for classifying distal RTA and predicting hearing loss and red blood cell deformability.
Genetic Basis of Kidney Tubular Disorders Click to view more details →